Skip to main content
Company
Overview
Management
Supervisory Board
Research & Development
Portfolio overview
ADC technology
ATAC Projects
Out-licensed product candidates
Funded projects
Publications
Scientific posters
Partnering
Press & Investors
Strategy and Facts
Strategy
Facts
Shareholder information
Share, Shareholder Structure, Basic Information
Financing History
Analysts
Capital Increase
Announcements
Press Releases and Ad-hoc Announcements
Financial Reports
Voting Rights
Directors' Dealings
Calendar and Presentations
Conferences & Presentations
Financial Calendar
Annual General Meeting
Corporate Governance
Corporate Bodies and Shareholdings
Statement on Corporate Governance
Declaration of Conformity
Articles of Association
Rules of Procedure of the Supervisory Board
Remuneration system of the Management Board and Supervisory Board
Remuneration Reports
Compliance
Code of Conduct
Whistleblower system
Newsletter subscription
Career
Overview
Job offers
Application process
Contact
Imprint
Privacy Policy
Disclaimer
Supplier & partners
Contact
English
Deutsch
Company
Overview
Management
Supervisory Board
Research & Development
Portfolio overview
ADC technology
ATAC Projects
Out-licensed product candidates
Funded projects
Publications
Scientific posters
Partnering
Press & Investors
Strategy and Facts
Strategy
Facts
Shareholder information
Share, Shareholder Structure, Basic Information
Financing History
Analysts
Capital Increase
Announcements
Press Releases and Ad-hoc Announcements
Financial Reports
Voting Rights
Directors' Dealings
Calendar and Presentations
Conferences & Presentations
Financial Calendar
Annual General Meeting
Corporate Governance
Corporate Bodies and Shareholdings
Statement on Corporate Governance
Declaration of Conformity
Articles of Association
Rules of Procedure of the Supervisory Board
Remuneration system of the Management Board and Supervisory Board
Remuneration Reports
Compliance
Code of Conduct
Whistleblower system
Newsletter subscription
Career
Overview
Job offers
Application process
Show all
2023
2022
2021
2020
2019
Press Releases and Ad-hoc Announcements
19 September 2023
PR: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101
PDF
08 August 2023
PR: Heidelberg Pharma’s Partner Takeda Reached Development Milestone
PDF
13 July 2023
PR: Heidelberg Pharma Reports on First Half-Year 2023 and the Course of Business
PDF
29 June 2023
AH: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics
PDF
25 May 2023
PR: Heidelberg Pharma reports on the results of the Annual General Meeting 2023
PDF
05 May 2023
PR: Heidelberg Pharma appoints Chief Financial Officer
PDF
13 April 2023
PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2023
PDF
04 April 2023
PR: Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023
PDF
24 March 2023
PR: Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business
PDF
